Literature DB >> 22095489

A rare S33C mutation of CTNNB1 encoding β-catenin in a parathyroid adenoma found in an Italian primary hyperparathyroid cohort.

Vito Guarnieri, Filomena Baorda, Claudia Battista, Michele Bisceglia, Teresa Balsamo, Elisa Gruppioni, Michelangelo Fiorentino, Lucia A Muscarella, Michelina Coco, Raffaela Barbano, Sabrina Corbetta, Anna Spada, David E C Cole, Lucie Canaff, Geoffrey N Hendy, Massimo Carella, Alfredo Scillitani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22095489     DOI： 10.1007/s12020-011-9558-y

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  10 in total

1.  Ruling out a suspect: the role of beta-catenin mutation in benign parathyroid neoplasia.

Authors:  William F Simonds
Journal:  J Clin Endocrinol Metab       Date:  2007-04       Impact factor: 5.958

2.  Epidemiology of primary hyperparathyroidism in Europe.

Authors:  Silvano Adami; Claudio Marcocci; Davide Gatti
Journal:  J Bone Miner Res       Date:  2002-11       Impact factor: 6.741

3.  Accumulation of nonphosphorylated beta-catenin and c-myc in primary and uremic secondary hyperparathyroid tumors.

Authors:  Peyman Björklund; Göran Akerström; Gunnar Westin
Journal:  J Clin Endocrinol Metab       Date:  2006-10-17       Impact factor: 5.958

4.  Lack of S37A CTNNB1/β-catenin mutations in a Swedish cohort of 98 parathyroid adenomas.

Authors:  Felix Haglund; Adam Andreasson; Inga-Lena Nilsson; Anders Höög; Catharina Larsson; C Christofer Juhlin
Journal:  Clin Endocrinol (Oxf)       Date:  2010-10       Impact factor: 3.478

5.  Immunohistochemistry of cyclin D1 and beta-catenin, and mutational analysis of exon 3 of beta-catenin gene in parathyroid adenomas.

Authors:  Satoshi Ikeda; Yasuyo Ishizaki; Yosuke Shimizu; Masahiko Fujimori; Yasutomo Ojima; Masazumi Okajima; Keizo Sugino; Toshimasa Asahara
Journal:  Int J Oncol       Date:  2002-03       Impact factor: 5.650

6.  Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas.

Authors:  C Christofer Juhlin; Felix Haglund; Andrea Villablanca; Lars Forsberg; Kerstin Sandelin; Robert Bränström; Catharina Larsson; Anders Höög
Journal:  Int J Oncol       Date:  2009-02       Impact factor: 5.650

7.  Absence of stabilizing mutations of beta-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas.

Authors:  Jessica Costa-Guda; Andrew Arnold
Journal:  J Clin Endocrinol Metab       Date:  2007-02-06       Impact factor: 5.958

8.  Beta-catenin activation is not involved in sporadic parathyroid carcinomas and adenomas.

Authors:  F Cetani; E Pardi; C Banti; P Collecchi; P Viacava; S Borsari; G Fanelli; A G Naccarato; F Saponaro; P Berti; P Miccoli; A Pinchera; C Marcocci
Journal:  Endocr Relat Cancer       Date:  2010-01-29       Impact factor: 5.678

9.  Nuclear Accumulation of B-Catenin in Human Endocrine Tumors: Association with Ki-67 (MIB-1) Proliferative Activity.

Authors:  Shuho Semba; Ryoko Kusumi; Takuya Moriya; Hironobu Sasano
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

10.  Stabilizing mutation of CTNNB1/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients.

Authors:  Peyman Björklund; Daniel Lindberg; Göran Akerström; Gunnar Westin
Journal:  Mol Cancer       Date:  2008-06-09       Impact factor: 27.401
  10 in total
  7 in total

Review 1.  Epigenetic alterations in human parathyroid tumors.

Authors:  Chiara Verdelli; Irene Forno; Valentina Vaira; Sabrina Corbetta
Journal:  Endocrine       Date:  2015-02-27       Impact factor: 3.633

2.  Allelic imbalance in sporadic parathyroid carcinoma and evidence for its de novo origins.

Authors:  Jessica Costa-Guda; Yasuo Imanishi; Nallasivam Palanisamy; Norihiko Kawamata; H Phillip Koeffler; R S K Chaganti; Andrew Arnold
Journal:  Endocrine       Date:  2013-02-24       Impact factor: 3.633

3.  EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms.

Authors:  E Sanpaolo; M Miroballo; S Corbetta; C Verdelli; F Baorda; T Balsamo; P Graziano; F P Fabrizio; L Cinque; A Scillitani; L A Muscarella; Vito Guarnieri
Journal:  Endocrine       Date:  2016-02-15       Impact factor: 3.633

Review 4.  Molecular genetics in primary hyperparathyroidism: the role of genetic tests in differential diagnosis, disease prevention strategy, and therapeutic planning. A 2017 update.

Authors:  Francesca Marini; Luisella Cianferotti; Francesca Giusti; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2017-05-30

Review 5.  Genetic and epigenetic changes in sporadic endocrine tumors: parathyroid tumors.

Authors:  Jessica Costa-Guda; Andrew Arnold
Journal:  Mol Cell Endocrinol       Date:  2013-09-11       Impact factor: 4.102

6.  Evidence of a stabilizing mutation of β-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas.

Authors:  Lee F Starker; Annabelle L Fonseca; Annabelle Fonseca; Göran Akerström; Peyman Björklund; Gunnar Westin; Tobias Carling
Journal:  Endocrine       Date:  2012-05-11       Impact factor: 3.633

Review 7.  Diagnosis, management, histology and genetics of sporadic primary hyperparathyroidism: old knowledge with new tricks.

Authors:  Maria Mizamtsidi; Constantinos Nastos; George Mastorakos; Roberto Dina; Ioannis Vassiliou; Maria Gazouli; Fausto Palazzo
Journal:  Endocr Connect       Date:  2018-01-12       Impact factor: 3.335
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.